New cancer therapies target epigenetic switch
Cancers emerge from many different paths. One path begins early, in embryonic development, when a protein complex called PRC2, which regulates cell differentiation, identity, and plasticity, becomes dysfunctional. PRC2 has ...
Mar 11, 2026
0
8









